ArticleInternational orthopaedics2026
Secondary fragility fractures after hip fracture surgery in four thousand, four hundred and eighteen older adults: risk factors and internal validation of an interpretable machine-learning model.
Article in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSecondary fragility fractures remain a major complication after hip fracture surgery in older adults, yet individualized postoperative risk stratification remains challenging. We aimed to identify factors associated with secondary fragility fracture and internally validate an interpretable machine-learning model for three year refracture risk.
methodsWe retrospectively analyzed adults aged ≥ 65 years who underwent surgery for a first low-energy hip fracture between 2014 and 2021. Patients were followed for three years for secondary fragility fracture. Demographic, clinical, functional, and rehabilitation variables were extracted from electronic medical records. Cox regression with multiple imputation was performed to evaluate time-to-event associations. XGBoost was developed as the primary prediction model and compared with SVM and Cox regression. Model performance was assessed using a held-out test set and decision curve analysis.
resultsAmong 4,418 patients, 594 (13.4%) sustained a secondary fragility fracture. Increased refracture risk was associated with older age, osteoporosis, low BMI, female sex, cardiovascular disease, visual impairment, syncope, non-standard rehabilitation, and postoperative Harris hip score < 80. In the test set, XGBoost achieved an AUC of 0.701 (95% CI, 0.657-0.743), with 61.8% sensitivity and 67.2% specificity at the default threshold. Decision curve analysis demonstrated the highest net benefit for XGBoost across threshold probabilities of approximately 7%-32%.
conclusionsSecondary fragility fractures were associated with skeletal fragility, fall-related vulnerability, and impaired postoperative recovery. The interpretable XGBoost model showed moderate discrimination and potential clinical utility as an adjunctive screening tool to identify patients who may benefit from intensified secondary prevention. External validation and prospective evaluation are required before routine clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.